<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1067139</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2022.1067139</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>SiO<sub>2</sub> nanosphere coated tough catheter with superhydrophobic surface for improving the antibacteria and hemocompatibility</article-title>
<alt-title alt-title-type="left-running-head">Zhang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2022.1067139">10.3389/fbioe.2022.1067139</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Weixing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2048388/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Juan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Tonghe</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1402886/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Ruilan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Critical Care Medicine</institution>, <institution>School of Medicine</institution>, <institution>Shanghai General Hospital</institution>, <institution>Shanghai Jiao Tong University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>School of Chemistry and Chemical Engineering</institution>, <institution>Shanghai Engineering Research Center of Pharmaceutical Intelligent Equipment</institution>, <institution>Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Non-coding RNA</institution>, <institution>Institute for Frontier Medical Technology</institution>, <institution>Shanghai University of Engineering Science</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1014969/overview">Hengchong Shi</ext-link>, Changchun Institute of Applied Chemistry (CAS), China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2118672/overview">Kai Wang</ext-link>, Nankai University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2135663/overview">Wei Nie</ext-link>, Wake Forest Baptist Medical Center, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Ruilan Wang, <email>wangyusun@hotmail.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>1067139</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Zhang, Du, Zhu and Wang.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Zhang, Du, Zhu and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Catheter infection is the most common complication after vascular catheter placement, which seriously threatens the survival of critically ill patients. Although catheters with antibacterial drug coatings have been used, catheter infections have not been effectively resolved. In this research, a SiO<sub>2</sub> nanosphere-coated PTFE catheter (PTFE-SiO<sub>2</sub>) with enhanced antibacterial and excellent mechanical properties was prepared <italic>via</italic> dopamine as a graft bridge. The microscopic morphology results show that the nanospheres are uniformly dispersed on the surface of the catheter. The physicochemical characterization confirmed that PTFE-SiO<sub>2</sub> had reliable bending resistance properties, superhydrophobicity, and cytocompatibility and could inhibit thrombosis. Antibacterial results revealed that PTFE-SiO<sub>2</sub> could hinder the reproduction of <italic>E. coli</italic> and <italic>S. aureus</italic>. This research demonstrates the hydroxyl-rich materials obtained by hydroboration oxidation have the advantages of better dispersion of functional coatings, indicating their potential for helpful modification of catheters.</p>
</abstract>
<kwd-group>
<kwd>superhydrophobic</kwd>
<kwd>SiO<sub>2</sub> nanosphere</kwd>
<kwd>catheter</kwd>
<kwd>antibacterial</kwd>
<kwd>blood compatibility</kwd>
</kwd-group>
<contract-sponsor id="cn001">Science and Technology Commission of Shanghai Municipality<named-content content-type="fundref-id">10.13039/501100003399</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Long-term intravenous fluid rehydration, central venous pressure and arterial monitoring, hemodialysis, and ECMO are important treatment methods in the critical care department through the placement of central venous catheters, hemodialysis catheters, and radial artery catheters (<xref ref-type="bibr" rid="B12">Gilbert et al., 2013</xref>; <xref ref-type="bibr" rid="B28">Shimizu et al., 2020</xref>; <xref ref-type="bibr" rid="B26">Schalk et al., 2022</xref>). However, catheter-related infection is a common and severe complication after implantation, which often requires removal of the catheter, performing catheter end and blood culture to determine the source of infection and bacterial species (<xref ref-type="bibr" rid="B11">Ferreira et al., 2020</xref>; <xref ref-type="bibr" rid="B5">Brescia et al., 2021</xref>). Finally, antibiotics are administered, and the catheter is reinserted at another site. The infectious bacteria associated with the catheter is MASA. Due to the poor antibacterial effect of most antibiotics, the emergence of super bacteria has caused great harm to human health. This causes pain for the patient, increases the cost of treatment, and increases the risk of other complications (<xref ref-type="bibr" rid="B2">Akhrass et al., 2011</xref>; <xref ref-type="bibr" rid="B17">Jana et al., 2018</xref>).</p>
<p>Previous studies have shown that bacteria&#x2019;s rapid, nonspecific adhesion to the hydrophilic and lipophilic groups on the catheter surface is the initial cause of catheter infection (<xref ref-type="bibr" rid="B20">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="B1">Alvarenga et al., 2020</xref>; <xref ref-type="bibr" rid="B18">Li et al., 2020</xref>). The effect of bacterial adhesion depends on the microscopic topography and chemical properties of the catheter surface, as well as the characteristics of the bacteria (<xref ref-type="bibr" rid="B22">Monzillo et al., 2012</xref>; <xref ref-type="bibr" rid="B20">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="B30">Yu et al., 2017</xref>; <xref ref-type="bibr" rid="B10">Faustino et al., 2020</xref>; <xref ref-type="bibr" rid="B29">Yu et al., 2021</xref>). How to reduce the colonization of bacteria in the catheter and avoid the formation of biofilm, thereby reducing the occurrence of catheter infection and the difficulty of treatment, has increasingly become a fundamental problem in clinical medicine, and more and more studies are constantly proposing new methods to solve this problem (<xref ref-type="bibr" rid="B13">Goncalves et al., 2014</xref>; <xref ref-type="bibr" rid="B25">Radu Mihu et al., 2017</xref>; <xref ref-type="bibr" rid="B32">Zhang et al., 2019</xref>; <xref ref-type="bibr" rid="B14">Gunaratnam et al., 2020</xref>). The current research on catheter-related infection globally mainly focuses on the antibacterial treatment after catheter infection. Once infected, high-grade antibiotics are required for treatment. In terms of prevention, the primary method is to coat the catheter with antibiotics. There are currently dialysis catheters that use coatings such as bismuth, which reduce bacterial colonization and thus film formation (<xref ref-type="bibr" rid="B27">Schindler et al., 2010</xref>; <xref ref-type="bibr" rid="B3">Balikci et al., 2021</xref>; <xref ref-type="bibr" rid="B24">Pant et al., 2022</xref>).</p>
<p>In addition to coating antibacterial drugs on catheters, finding the best material for antibacterial is also one of the directions we need to work on. Inspired by the origin of bacterial adhesion, we expect to develop a new type of coated vascular catheter that can effectively isolate bacterial adhesion factors. Therefore, we plan to design a novel anti-infective superhydrophobic nanocomposite-coated vascular catheter. The catheter coating and base material will not use antibacterial drugs, and the anti-infection purpose is mainly achieved by the superhydrophobicity of the surfaces of material.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Materials</title>
<p>Commercial venous catheters were purchased from Arrow International, Inc. (Cleveland, United States). Both PTFE membranes (FP301350, with 0.25&#xa0;mm thickness) and PTFE catheters (with 0.6&#xa0;mm wall thickness and 1.0&#xa0;mm inner diamater) were purchased from Goodfellow Tading Co., Ltd. (Shanghai, China). SiO<sub>2</sub> nanosphere powder (average particle size is 20&#xa0;nm) were purchased from Suzhou Vmicronano New Materials Co., Ltd. (Suzhou, China). Benzoin (purity &#x2265; 99.5%), potassium tert-butoxide (purity &#x2265; 99.9%), and borane tetrahydrofuran (purity &#x2265; 99.99%) were purchased from Adamas Reagent Co., Ltd. (Shanghai, China). Dimethyl sulfoxide (DMSO), tetrahydrofuran (THF), anhydrous ethanol (EtOH, purity &#x2265; 99.99%) were obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Other reagents and materials are not treated before use unless otherwise specified.</p>
</sec>
<sec id="s2-2">
<title>2.2 Surface modification of PTFE membrane and catheter</title>
<sec id="s2-2-1">
<title>2.2.1 Preparation of PTFE-OH membrane and catheter</title>
<p>The circular PEFE membranes with a diameter of 14&#xa0;mm and PTFE catheters with 0.6&#xa0;mm thickness and 1.0&#xa0;mm inner diamater (uniformly named PTFE) were ultrasonically cleaned in 75% medical alcohol for 30&#xa0;min, and then freeze-dried in vacuum for subsequent experiments, respectively.</p>
<p>Firstly, 1.5&#xa0;g of benzoin and 5.1&#xa0;g of potassium tert-butoxide were dissolved in 10 and 50&#xa0;ml of dimethyl sulfoxide, respectively. Then, the above two harvested solutions were mixed until present clear and homogeneous (<xref ref-type="bibr" rid="B7">Costello and McCarthy, 1984</xref>). Secondly, The cleaned PTFE was added to the mixed solution, and the reaction was continued for 36&#xa0;h at 54&#xb0;C in a constant temperature water bath. After the reaction was over, the modified PTFE were washed twice with tetrahydrofuran reagent, following washed with deionized water for 5&#xa0;times. Finally, the modified PTFE were freeze-dried for 48&#xa0;h, namely PTFE-M.</p>
<p>Finally, hydroxyl groups were introduced on the surface of PTFE according to the hydroboration oxidation reaction (<xref ref-type="bibr" rid="B21">Meng et al., 2015</xref>; <xref ref-type="bibr" rid="B8">Dan et al., 2020</xref>): PTFE-M was added to 10&#xa0;ml borane tetrahydrofuran solution in three-necked flask. Then the three-necked flask was sealed, and the reaction was carried out at room temperature for 12&#xa0;h. The borane tetrahydrofuran solution was then transferred out, and then 10&#xa0;ml of deionized water, 10&#xa0;ml of 3&#xa0;mol/L NaOH solution and 10&#xa0;ml of 30% H<sub>2</sub>O<sub>2</sub> were added in sequence. Finally, place the three-necked flask into the prepared ice-water mixture and ice-bath for 3&#xa0;h under a magnetic stirrer. After the reaction is completed, the modified PTFE is washed with dilute hydrochloric acid solution, alkene sodium hydroxide solution and deionized water in sequence. Finally, the hydroxylated PTFE were vacuumed in a desiccator for 48&#xa0;h to remove redisual solvent and namely PTFE-OH.</p>
</sec>
<sec id="s2-2-2">
<title>2.2.2 Preparation of PTFE-SiO<sub>2</sub> membrane and catheter</title>
<p>First, 200&#xa0;mg of dopamine and 2&#xa0;g of nanospheres were added to a Tris (pH &#x3d; 8.5) solution, which were prepared using 200&#xa0;ml deionized water. Then PTFE-OH was added to the above solution which was mixed well and soaked for 4&#xa0;h. Finally, the modified PTFE were washed thoroughly with deionized water, following freeze-dried in a vacuum freeze dryer for 48&#xa0;h to remove redisual solvent and namely PTFE-SiO<sub>2</sub>.</p>
</sec>
</sec>
<sec id="s2-3">
<title>2.3 Characterization and tests of prepared membrane or catheter</title>
<p>The morphology and surface structure of modified PTFE were carried out using a scanning electron microscope (SEM, Phenom XL, Netherlands) operating with sputter gold plating for 35&#xa0;s at 5&#xa0;mA at an accelerating voltage of 10&#xa0;kV. FTIR spectra of modified PTFE were analyzed on a Nicolet 6700 spectrometer (Thermo Fisher, United States) in the spectrum range of 500 and 4000&#xa0;cm<sup>&#x2212;1</sup> with a resolution of 1&#xa0;cm<sup>&#x2212;1</sup>, setting 30 scans for a single analysis. A contact angle measuring device (JC 2000D 2A, Shanghai Zhongchen Digital Technology Equipment Co., Ltd., China) was used to testing the wettability of modified PTFE. In this testing, 0.02&#xa0;ml deionized water was added to the sample, and three groups of parallel samples were taken from each group of PTFE to test the water contact angle and calculate the average value.</p>
<p>High-precision mechanical property testing machine (HY-025CS, Shanghai Hengyu Instrument Co., Ltd., China) with a transducer with a load range of 0&#x2013;1000&#xa0;N was employed to testing the compressive performance of prepared catheter in dry conditions at room temperature. Catheter with a size of 2&#xa0;mm inner diameter, 50&#xa0;mm length, and approximately 0.5&#xa0;mm in wall thickness were used for radial compression testing. The cyclic compression tests at 50% of the outer diameter of catheters were repeatedly performed 1000 times at a fixed rate of 0.2&#xa0;mm/min. Each test was repeated five times during mechanical analysis.</p>
</sec>
<sec id="s2-4">
<title>2.4 Cell culture and cytocompatibility evaluation</title>
<p>Mice fibroblast cells (L929) were cultured with growth medium consisting of dulbecco&#x2019;s modified eagle medium (DMEM), 10% fetal bovine serum and 1% penicillin/streptomycin. Before cell seeding, the commercial membranes, PTFE, and PTFE-SiO<sub>2</sub> membranes were cut into discs with a diameter of 14&#xa0;mm, then placed into 24-well plates one by one, following covered with sterilized stainless rings, respectively. Each sample was sterilized in 75% ethanol for 12&#xa0;h and then washed with PBS three times, finally irradiated with ultraviolet for 2&#xa0;h and socked in growth medium for incubation overnight. HUVECs were seeded at a density of 1.5 &#xd7; 10<sup>4</sup> cells/well, and the culture medium was maintained to be replaced every 2&#xa0;days.</p>
<p>The cell viability of L929 was tested by using the Cell Counting Kit-8 (CCK-8). The cells were cultured in commercial membranes, PTFE, and PTFE-SiO<sub>2</sub> membranes for 1&#xa0;day, 3&#xa0;days, and 5&#xa0;days, respectively. When the set culture time point, the well plate was taken from the CO<sub>2</sub> incubator, and then a series of operations as removal medium, wash samples in well with PBS, adding 360&#xa0;&#x3bc;L DMEM medium and 40&#xa0;&#x3bc;L CCK-8 solution into the lucifugal well plate in sequence. After 1&#xa0;h incubation in CO<sub>2</sub> incubator, The optical density (OD) value was measured with a microplate reader at a wavelength of 450&#xa0;nm.</p>
<p>Before the cells SEM images test, the cultured L929 were fixed with 4% paraformaldehyde and dehydrated by gradient ethanol (30%, 50%, 70%, 80%, 90%, 95%, and 100%) on the 3rd day and the morphology carried out using a scanning electron microscope (SEM, Phenom XL, Netherlands) operating with sputter gold plating for 35&#xa0;s at 5&#xa0;mA at an accelerating voltage of 10&#xa0;kV, respectively.</p>
<p>Additionally, the live cells (green) and dead cells (red) were stained with Calcein-AM/PI after 3&#xa0;days&#x2019; culture, respectively. The dyed samples were observed immediately under the TS100 fluorescence microscope (Nikon, Japan).</p>
</sec>
<sec id="s2-5">
<title>2.5 Blood compatibility test <italic>in vitro</italic>
</title>
<p>Fresh blood, which was drawn from the marginal vein, and 3.2% sodium citrate solution in a volume ratio of 9:1 (v/v) were collected using a plastic vacuum blood collection tube (2.7 ml, Becton Dickinson, United States), containing 3.2% sodium citrate solution. All animal experimental protocols are in accordance with the policy of the Institutional Review Board for Human Investigations at School of Medicine of Shanghai Jiao Tong University. Detailed procedures are available in the <xref ref-type="sec" rid="s9">Supplementary Material</xref>.</p>
</sec>
<sec id="s2-6">
<title>2.6 Testing of antibacterial activity <italic>in vitro</italic>
</title>
<p>
<italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>, BCRC 10451) and <italic>Escherichia coli</italic> (<italic>E. coli</italic>, BCRC 11634) were used to assess the antibacterial ability of commercial membranes, PTFE, and PTFE-SiO<sub>2</sub> membranes. Antibacterial activities were investigated by agar disc diffusion assay as described previously.</p>
<p>Firstly, commercial membranes, PTFE, and PTFE-SiO<sub>2</sub> membranes were pruned into rounded membranes with a diameter of 14&#xa0;mm. Then, circular membranes were irradiated under an ultraviolet lamp for 12&#xa0;h, following fumigated with ethanol overnight for thorough sterilization and stored in the bechtop for further testing or evaluation. For non-quantitative synthesis, the bacterial inhibition ring of the <italic>E. coli</italic> and <italic>S. aureus</italic> cultured on the LB agar plates was assessed. In short, <italic>E. coli</italic> and <italic>S. aureus</italic> infection fluid (200&#xa0;&#x3bc;L) was the first diffusion into the agar plates and the experiment mats (commercial, PTFE, and PTFE-SiO<sub>2</sub> circular membranes) with a diameter of 14&#xa0;mm and a thickness of about 300&#xa0;&#x3bc;m were attached to the agar plate. After incubation at 37&#xb0;C for 24&#xa0;h, the bacterial inhibition ring of each specimen on the plate was visually measured. The inner and outer diameters and calculated diameter distinction were analyzed for evaluating the antimicrobial activity of prepared circular nanofibrous mats.</p>
</sec>
<sec id="s2-7">
<title>2.7 Biofilm experiment of catheter <italic>in vitro</italic>
</title>
<p>First, all the catheter (commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter) were cut into multiple segments with 5&#xa0;mm length, following ultrasonic washed with distilled water and ethanol for 5&#xa0;min, respectively. Then, all the samples were immersed into 200&#xa0;&#x3bc;L of selected medium (BHI for VRE and TSB supplemented with 1% glucose for <italic>S. aureus</italic>) in a 96-well plate after vacuum freeze drying for 48&#xa0;h. 1.0 &#xd7; 10<sup>6</sup>&#xa0;CFU/ml bacteria suspension was made by diluting in 10&#xa0;mM PBS with pH &#x3d; 7.4 from overnight culture. 8&#xa0;&#x3bc;L of the above prepared diluted bacteria suspension was added to each well, following the plate was incubated at 37&#xb0;C for 24&#xa0;h (<xref ref-type="bibr" rid="B33">Zhou et al., 2017</xref>). All the above samples were then removed and washed gently thrice with PBS to remove unattached bacteria. Then, all the samples were fixed with 4% paraformaldehyde and dehydrated by gradient ethanol (10%, 30%, 50%, 60%, 75%, 80%, 90%, and 100%) and the morphology carried out using a scanning electron microscope (SEM, Phenom XL, Netherlands) operating with sputter gold plating for 35&#xa0;s at 5&#xa0;mA at an accelerating voltage of 10&#xa0;kV, respectively.</p>
</sec>
<sec id="s2-8">
<title>2.8 Statistical analysis</title>
<p>Origin 9.0 statistical software (Origin Lab Inc., United States), one-way ANOVA and Tukey&#x2019;s test were applied to statistical analysis of the data. All data are expressed as mean &#xb1; standard deviation (Mean &#xb1; SD). <italic>p</italic>-values &#x3c; 0.05 (&#x2a;) were deemed to be statistically significant. &#x2a; indicates <italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a; indicates <italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a; indicates <italic>p</italic> &#x3c; 0.001.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Microstructure and surface phychemical properties of catheter</title>
<p>As a conduit material, PTFE has advantages in mechanical properties. However, PTFE is an inert material, which limits its application in medical catheters. In order to change the chemical inertness of the surface of PTFE catheter and improve the biocompatibility of PTFE, a very active unsaturated carbon chain layer was formed on the surface of PTFE by treating the mixed solution of benzoin and potassium tert butoxide. Then, a large number of hydroxyl groups were reactive grafted on the surface of PTFE membrane by borohydride oxidation reaction, following grafted SiO<sub>2</sub> nanosphere on the surface of PTFE matrix through dopamine bridging, which presented strong adhesion between the hydroxyl groups of polydopamine and the SiO<sub>2</sub> nanosphere surface. Macroscopically, the catheter could maintain its tubular shape after being treatment with organic solution (<xref ref-type="fig" rid="F1">Figure 1A</xref>). We obtained catheters with a length of 25&#xa0;mm and an inner diameter of 1.5&#xa0;mm (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The presence of as coated SiO<sub>2</sub> nanosphere was verified <italic>via</italic> FTIR spectra, by which we demonstrated that PTFE-SiO<sub>2</sub> catheter received more characteristic peak of stretching vibration of Si-O bond at 958&#xa0;cm<sup>&#x2212;1</sup> after coating (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>(A)</bold> The digital photos of commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter, respectively; <bold>(B)</bold> FTIR spectra of commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter, respectively; <bold>(C)</bold> and <bold>(D)</bold> Water contact angle of the lumen surface of the inner surfaces of PTFE catheter, and PTFE-SiO<sub>2</sub> catheter at the 5&#xa0;s time point, respectively.</p>
</caption>
<graphic xlink:href="fbioe-10-1067139-g001.tif"/>
</fig>
<p>With the increasing attention of superhydrophobic surfaces, the reduction of bacterial adhesion by superhydrophobic surfaces has also been considered as an effective antibacterial method (<xref ref-type="bibr" rid="B23">Ozkan et al., 2021</xref>; <xref ref-type="bibr" rid="B19">Li et al., 2022</xref>). The superhydrophobic surface interface of PTFE catheter play an important role in the adsorption and the adhesion of bacteria. As shown in <xref ref-type="fig" rid="F1">Figures 1C</xref>, D, the water contact angle values of the lumen surface of the inner surfaces of PTFE catheter and PTFE-SiO<sub>2</sub> catheter were 110.9&#xb0; &#xb1; 1.8&#xb0; and 151.2&#xb0; &#xb1; 1.5&#xb0; at 5&#xa0;s, respectively. The SiO<sub>2</sub> nanosphere-coated PTFE catheter exhibits stronger hydrophobicity. The antibacterial mechanism of superhydrophobic surfaces is that bacteria are more likely to adhere to surfaces with high surface energy, while superhydrophobic surfaces have lower surface energy, which is not conducive to the adhesion of bacteria (<xref ref-type="bibr" rid="B4">Boinovich et al., 2018</xref>; <xref ref-type="bibr" rid="B16">Huang et al., 2018</xref>; <xref ref-type="bibr" rid="B31">Zhan et al., 2021</xref>). Moreover, the air layer trapped by the micro-nanostructure will isolate the bacteria from the SiO<sub>2</sub> coating. When the superhydrophobic catheter is in contact with bacteria, the contact area between the coating and the colony will reducing due to the effect of the air layer, which can avoid the formation of biofilm on the surface of the catheter, and finally achieve the effect of bacteriostasis.</p>
<p>The dispersion of the SiO<sub>2</sub> coating is also one of the main factors affecting the antibacterial effect of the catheter surface. The scanning electron microscope images in <xref ref-type="fig" rid="F2">Figure 2</xref> showed that the coating consists of many micro- and nano-scale protrusions and pits. These micro-nano structures are mainly formed by the accumulation of nano-SiO<sub>2</sub> particles. The nano-SiO<sub>2</sub> is tightly fixed on the surface of the PTFE substrate by the dopamine matrix, which improves the mechanical stability of the surface of the superhydrophobic coating. Comparing the commerical group and the PTFE group, it is not difficult to find that the immobilized SiO<sub>2</sub> using dopamine after hydroxylation treatment not only shows a higher graft density, but also disperses more uniformly on the PTFE surface.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The suefaces SEM images of commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter, respectively.</p>
</caption>
<graphic xlink:href="fbioe-10-1067139-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Mechanical properties</title>
<p>In order to clarify whether the original mechanical properties of PTFE catheters were changed after the grafting of SiO<sub>2</sub> nanospheres, mechanical properties experiments were carried out. The results of radial cyclic compression at 50% of the outer diameter of catheters after 1000 cycle compressive fatigue tests are shown in <xref ref-type="fig" rid="F3">Figure 3</xref>. As shown in <xref ref-type="fig" rid="F3">Figures 3A,B</xref>, the compressive and compressive modulus after 1000 cycle compressive fatigue tests of PTFE-SiO<sub>2</sub> catheter were significantly lower than those of PTFE group, but consistently superior to the commerical group. According to the standard guidelines of three-point bending test of ASTM F2606-09 as present in <xref ref-type="fig" rid="F3">Figures 3C</xref>, D, all the samples were bendable and returned to their original shape without any visible damage and permanent deformation. Therefore, the modified catheter still maintains reliable bending resistance, which will be sufficient to support the catheter against any possible external force during surgical operation.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>
<bold>(A)</bold> Maximum compressive force and <bold>(B)</bold> compressive modulus after 1000 cycle compressive fatigue tests; <bold>(C)</bold> Images of three-point bending tests; <bold>(D)</bold> Typical the first and one thousandth loading-unloading compression cycle curves of commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter.</p>
</caption>
<graphic xlink:href="fbioe-10-1067139-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Cytocompatibility and hemocompatibility <italic>in vitro</italic>
</title>
<p>To test the biocompatibility of the samples before and after modification, the same amount of L929 was inoculated on each sample. As shown in <xref ref-type="fig" rid="F4">Figures 4A,B</xref>, the adhesion ability of the PTFE-SiO<sub>2</sub> group to L929 was higher than that of the commercial group and the PTFE group but still lower than that of the cover slips group. <xref ref-type="fig" rid="F4">Figures 4C,D</xref> show that by day 3, the number of viable cells in the cover slips group and the commerical group was less than that in the other two groups. The PTFE-SiO<sub>2</sub> group had the smallest viable cells, mainly due to the hydrophobic surface and chemical inertness caused by the fluorocarbon structure. The SiO<sub>2</sub> nanocluster structure is unsuitable for cell adhesion and proliferation.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>CCK-8 assay of <bold>(A)</bold> the adhesion viability after 24&#xa0;h culture and <bold>(B)</bold> proliferation viability after 1, 3, and 5&#xa0;days culture of HUVECs onto cover slips, commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter, respectively; <bold>(C)</bold> Quantitative number measurements of L929 cells on the inner surfaces of cover slips, commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter after culturing for 3&#xa0;days; <bold>(D)</bold> Live/dead staining viability assay of L929 cells cultured on the inner surfaces of cover slips, commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter after culturing for 3&#xa0;days.</p>
</caption>
<graphic xlink:href="fbioe-10-1067139-g004.tif"/>
</fig>
<p>After vascular puncture, the catheter stays in the body for a long time, which can easily lead to nonspecific protein adsorption, microbial infection, and blood coagulation (<xref ref-type="bibr" rid="B15">Hitz et al., 2012</xref>; <xref ref-type="bibr" rid="B9">Erathodiyil et al., 2020</xref>). These phenomena eventually lead to deep vein thrombosis (PICC-DVT), pulmonary embolism (PE) due to thrombus shedding, and catheter-related bloodstream infections (CRBSIs) due to microbial infections. Currently, drugs such as heparin and antibiotics are injected into patients to reduce catheter-related complications. However, neither heparin nor antibiotics maintain long-term efficacy in the body. Repeated injections of chemicals will not only reduce the patient&#x2019;s immunity and cause suffering from drug side effects. Therefore, optimizing and modifying existing materials is an effective measure to reduce catheter-related complications and improve the anticoagulant and antibacterial properties of catheters.</p>
<p>The anticoagulant property of all samples could be evaluated directly by whole blood clotting time, plasma recalcification time, quantification of relative hemolysis rate, and quantification of lactate dehydrogenase activity. We assessed the whole blood clotting of catheter by the whole blood clotting time test. After the whole blood incubation, the absorbance of the supernatant was measured at 540&#xa0;nm, as shown in <xref ref-type="fig" rid="F5">Figure 5A</xref>. Compared with the other two groups, the PTFE catheter coated with SiO<sub>2</sub> nanospheres had the maximum absorbance at any time point. The higher the absorbance, the higher the hemoglobin content in the supernatant, which means that there are more blood cells in the free state, less blood cells that produce coagulation, and the slower the coagulation speed. All in all, under the same experimental conditions, the clotting time of the control group was significantly shorter, indicating that the coated-modified PTFE catheter has highly hydrophobic properties and can resist the adhesion of proteins to the material surface. Therefore, PTFE-SiO<sub>2</sub> catheter can reduce the adhesion of blood cells and has outstanding anticoagulant properties.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>
<bold>(A)</bold> Whole blood clotting time <bold>(B)</bold> Plasma recalcification time; <bold>(C)</bold> Quantification of relative hemolysis rate; <bold>(D)</bold> Platelet deposition determined by lactate dehydrogenase assay. (For plasma recalcification time test, TCPs exposed to PPP with and without CaCl<sub>2</sub> were used as positive control and negative control, respectively; For hemolysis test, water and 0.9% normal saline (NS) serve as positive and negative groups, respectively; <italic>n &#x3d; 5, &#x2a;p</italic> &#x3c; <italic>0.05</italic>, <italic>&#x2a;&#x2a;p</italic> &#x3c; <italic>0.01</italic>).</p>
</caption>
<graphic xlink:href="fbioe-10-1067139-g005.tif"/>
</fig>
<p>As we all know, the essence of blood coagulation is the process of fibrinogen in plasma from soluble to insoluble, and blood coagulation is divided into two types: intrinsic coagulation and extrinsic coagulation. All coagulation factors involved in intrinsic coagulation are provided by plasma. When the plasma comes into contact with the material, the electrical charge on the surface activates the coagulation factors in the plasma. The plasma recalcification curve is a method used to characterize the endogenous coagulation system. The recalcification time is the time it takes for the plasma to coagulate after removing the calcium source and then adding Ca<sup>2&#x2b;</sup>. The kinetics of plasma recalcification can be seen in <xref ref-type="fig" rid="F5">Figure 5B</xref> for the three water conduits, the positive control group and the negative control group. The positive control has the fastest clot formation time at 15&#xa0;min, while the clot formation time of the commerical and PTFE group were 20 and 24&#xa0;min, respectively. Notably, the PTFE-SiO<sub>2</sub> group consistently kept a low absorbance and closed to the negative control without emerging the inflection point. The above results indicate that the PTFE-SiO<sub>2</sub> group has a superhydrophobic surface interface effect, so the activation of endogenous coagulation is less, and the anticoagulation performance of the catheter is improved.</p>
<p>The hemolysis rate of a material refers to the degree to which hemoglobin is lysed by erythrocytes after the material is in contact with erythrocytes. According to international standards, the hemolysis rate of biological materials should be less than 5% (<xref ref-type="bibr" rid="B34">Zhu et al., 2021</xref>). <xref ref-type="fig" rid="F5">Figure 5C</xref> is the hemolysis rate of PTFE catheters before and after coating. As shown in the figure, the hemolysis rate of the uncoated PTFE catheter was 1.756%, while after the SiO<sub>2</sub> nanosphere coating, the anti-hemolysis ability was significantly reduced. In conclusion, PTFE-SiO<sub>2</sub> had the best blood compatibility among all samples, and the hemolysis rate was only 0.521%, which was almost close to that of the negative control group.</p>
<p>The lactate dehydrogenase (LDH) activity of platelet adhesion on the inner surface of catheter after 2&#xa0;h incubation with rabbit platelet-rich plasma are shown in <xref ref-type="fig" rid="F5">Figure 5D</xref>. The deposition of adhered platelets on the inner surface of PTFE-SiO<sub>2</sub> catheter was 85 platelets/mm<sup>2</sup>, which was significantly reduced to 622 platelets/mm<sup>2</sup> for the PTFE catheter and to 2136 platelets/mm<sup>2</sup> for the commerical catheter. SiO<sub>2</sub> nanosphere coated-modified PTFE catheter adsorbed fewer platelets compared with the PTFE catheter, indicating that coated SiO<sub>2</sub> nanosphere not only significantly reduced platelet deposition but also efficiently suppressed the activation and transmutation of platelets.</p>
</sec>
<sec id="s3-4">
<title>3.4 Antibacterial effect <italic>in vitro</italic>
</title>
<p>After the catheter enters the blood vessel, some nonspecific proteins (polyglycan matrix, <italic>etc.</italic>) will form a thin film on the surface of the catheter. Bacteria will then stick to the film and increase, following a biofilm formed. Because the resulting biofilm is not recognized by tissues and the bacteria are not killed by the immune system, it can eventually lead to bacterial infections. The superhydrophobic surface is an effective method to limit the formation of biofilm, which can inhibit the adhesion of bacteria to the material surface.</p>
<p>The bactericidal effect on Gram-negative bacteria (<italic>Escherichia coli</italic>, <italic>E. coli</italic>) and Gram-positive bacteria (<italic>Staphylococcus aureus</italic>, <italic>S. aureus</italic>) was evaluated to determine whether the superhydrophobic SiO<sub>2</sub> nanosphere coating had a pronounced antibacterial effect. As shown in <xref ref-type="fig" rid="F6">Figure 6</xref>, after co-culture of PTFE-SiO<sub>2</sub> catheters on the solid medium of two bacteria, bacteriostatic circles appeared, and the areas of bacteriostatic processes were 4.05 and 8.75&#xa0;mm<sup>2</sup>, respectively. Compared the antibacterial effects of the three groups of samples, it can be found that the commercial group samples did not show evident antibacterial rings after co-culture on the two kinds of colony media, and the PTFE catheter only showed small antibacterial rings on the surface of the medium with <italic>S. aureus</italic>. These results indicate that the superhydrophobic conduit coated with SiO<sub>2</sub> nanospheres has specific antibacterial properties.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>
<bold>(A)</bold> Visual images of the antibacterial zone of catheter to <italic>Escherichia coli</italic> (<italic>E. coli</italic>) and <italic>Staphylococcus aureus</italic> (<italic>S. aureus</italic>) after incubation for 6&#xa0;h. Spot &#x2460;, &#x2461;, and &#x2462; represents commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter, respectively; of commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter, respectively; <bold>(B)</bold> and <bold>(C)</bold> Quantified antibacterial zone of commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter after 6&#xa0;h incubation with <italic>E. coli</italic> and <italic>S. aureus</italic>, respectively. (<italic>n &#x3d; 5, &#x2a;&#x2a;p</italic> &#x3c; <italic>0.01</italic>)</p>
</caption>
<graphic xlink:href="fbioe-10-1067139-g006.tif"/>
</fig>
<p>We also compared the bacteriostatic rate of the three groups of samples by colony statistical test. As shown in <xref ref-type="fig" rid="F7">Figure 7A</xref>, <italic>E. coli</italic> and <italic>S. aureus</italic> were cultured for 6&#xa0;h, respectively. Then, a certain amount of bacterial liquid was drawed and placed in a sterile centrifuge. After adding the three samples to the corresponding centrifuge tubes, the centrifuge tubes were placed in a constant temperature shaker for co-cultivation for a certain period of time, and the bacterial solution was diluted 10,000&#xa0;times. Then take 10&#xa0;&#x3bc;L of the diluted bacterial culture solution, spread it evenly on the surface of the petri dish containing the solid medium in one direction, place it in a constant temperature shaker for 6&#xa0;h, and count the number of colonies. After superhydrophobic modification using SiO<sub>2</sub> nanospheres, the antibacterial rate of the catheter against <italic>E. coli</italic> was enhanced from 39.7% to 52.1%, and the antibacterial rate against <italic>S. aureus</italic> was increased from 50.5% to 89.3% (as shown in <xref ref-type="fig" rid="F7">Figure 7B</xref>). It shows that the coating using SiO<sub>2</sub> nanospheres enhances the antibacterial activity of the PTFE catheter, which may due to the superhydrophobic coating of SiO<sub>2</sub> nanospheres not being conducive to the formation of the bacterial film.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Quantitative analysis of the antibacterial properties of catheter: <bold>(A)</bold> Conoly-counting assay of catheter against <italic>E. coli</italic> and <italic>S. aureus</italic>; <bold>(B)</bold> Antibacterial rate of catheter after 6&#xa0;h incubation with <italic>E. coli</italic> and <italic>S. aureus</italic> (quantitative analysis of colony statistics); <bold>(C)</bold> Quantitative analysis of photometric method after 6&#xa0;h incubation with <italic>E. coli</italic> and <italic>S. aureus</italic>. (<italic>n &#x3d; 5, &#x2a;p</italic> &#x3c; <italic>0.05</italic>, <italic>&#x2a;&#x2a;p</italic> &#x3c; <italic>0.01</italic>)</p>
</caption>
<graphic xlink:href="fbioe-10-1067139-g007.tif"/>
</fig>
<p>To illustrate that the modified PTFE catheter has prominent antibacterial properties, the antibacterial properties were quantitatively analyzed by photometry. As shown in <xref ref-type="fig" rid="F7">Figure 7C</xref>, after co-culturing the catheter with the bacterial solution for 6&#xa0;h, the absorbance of the commerical group and the PTFE group was significantly higher than that of the PTFE-SiO<sub>2</sub> group, regardless of whether it was <italic>E. coli</italic> and <italic>S. aureus</italic>. It shows that the catheter of the commercial group does not have antibacterial properties, which is consistent with the inhibition zone and colony statistics results. In conclusion, the antibacterial ability of the PTFE catheter was significantly improved after the layer modification.</p>
<p>Surface functionalization is an effective strategy to improve the application potential of medical catheters. Proper surface wettability is the key to improve the antibacterial ability of the catheter (<xref ref-type="bibr" rid="B6">Chauhan et al., 2014</xref>). The mechanism of antibacterial activity of SiO<sub>2</sub> nanosphere coated tough catheter against <italic>S. aureus</italic> was examined by SEM images. As in <xref ref-type="fig" rid="F8">Figure 8</xref>, SEM images showed large numbers of <italic>S. aureus</italic> on the suefaces of commerical catheter. On the surface of PTFE catheter, SEM images show the number of viable <italic>S. aureus</italic> to be greatly reduced, confirming the anti-<italic>S. aureus</italic> nature of the surface of electronegativity of PTFE. It is worth noting that although PTFE-SiO<sub>2</sub> catheter has a large contact angle, it also prevents the formation of <italic>S. aureus</italic> biofilm, possibly because of the large surface anionic charge of SiO<sub>2</sub>, which were uniformly distributed on the PTFE surface.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>SEM images of <italic>S. aureus</italic> on the surfaces of commerical catheter, PTFE catheter, and PTFE-SiO<sub>2</sub> catheter, respectively. (Yellow solid represent bacteria in biofilm).</p>
</caption>
<graphic xlink:href="fbioe-10-1067139-g008.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>In the present study, we developed a SiO<sub>2</sub> nanosphere-coated PTFE catheter (PTFE-SiO<sub>2</sub>) based on hydroxyl-rich materials obtained by hydroboration oxidation. SEM, FTIR, water contact angle, mechanical tests, cell and blood compatibility test <italic>in vitro</italic> were used to analyze the chemical structure, microstructure, surface wettability, cytocompatibility, and hemocompatibility of PTFE-SiO<sub>2</sub> catheter. The results show that the SiO<sub>2</sub> nanospheres can be uniformly dispersed on the surface of the PTFE catheter, and the coating will not significantly change the bending resistance of the catheter. Moreover, the catheter demonstrated a safe hemolysis rate of less than 5% while also not causing coagulation. Finally, antibacterial experiments showed that PTFE-SiO<sub>2</sub> catheter was the group with the highest antibacterial rate among the three groups. In conclusion, the SiO<sub>2</sub> nanospheres-coated PTFE catheter with regular morphology and high bending resistance property has a potential application prospect in anticoagulant and anti-infective catheters.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s9">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>WZ was responsible for the design of the experimental scheme and the writing of the paper; JD was responsible for the processing of experimental data; TZ was responsible for the revision of the paper; RW was responsible for the data review and revision of the paper.</p>
</sec>
<ack>
<p>The authors sincerely appreciate projects sponsored by Technology Support Project of Science and Technology Commission of Shanghai Municipality (19441906700).</p>
</ack>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s9">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2022.1067139/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2022.1067139/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarenga</surname>
<given-names>Dalila Junqueira</given-names>
</name>
<name>
<surname>Matias</surname>
<given-names>Laira Maria Faria</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>Lucas Martins</given-names>
</name>
<name>
<surname>Leao</surname>
<given-names>Luiz Paulo Melchior de Oliveira</given-names>
</name>
<name>
<surname>Hawkes</surname>
<given-names>Jamie Anthony</given-names>
</name>
<name>
<surname>Raimundo</surname>
<given-names>Breno Vilas Boas</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Exploring how structural changes to new Licarin A derivatives effects their bioactive properties against rapid growing mycobacteria and biofilm formation</article-title>. <source>Microb. Pathog.</source> <volume>144</volume>, <fpage>104203</fpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2020.104203</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akhrass</surname>
<given-names>Fadi Al</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>Hachem</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>Jamal A.</given-names>
</name>
<name>
<surname>Tarrand</surname>
<given-names>Jeffrey</given-names>
</name>
<name>
<surname>Kontoyiannis</surname>
<given-names>Dimitrios P.</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>Jyotsna</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Central venous catheter&#x2013;associated<italic>Nocardia</italic>Bacteremia in cancer patients</article-title>. <source>Emerg. Infect. Dis.</source> <volume>17</volume> (<issue>9</issue>), <fpage>1651</fpage>&#x2013;<lpage>1658</lpage>. <pub-id pub-id-type="doi">10.3201/eid1709.101810</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balikci</surname>
<given-names>Elif</given-names>
</name>
<name>
<surname>Yilmaz</surname>
<given-names>Bengi</given-names>
</name>
<name>
<surname>Tahmasebifar</surname>
<given-names>Aydin</given-names>
</name>
<name>
<surname>Turker Baran</surname>
<given-names>Erkan</given-names>
</name>
<name>
<surname>Kara</surname>
<given-names>Ekrem</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Surface modification strategies for hemodialysis catheters to preventcatheter&#x2013;relatedinfections: A review</article-title>. <source>J. Biomed. Mater. Res. Part B-Applied Biomaterials</source> <volume>109</volume> (<issue>3</issue>), <fpage>314</fpage>&#x2013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.b.34701</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boinovich</surname>
<given-names>Ludmila B.</given-names>
</name>
<name>
<surname>Modin</surname>
<given-names>Evgeny B.</given-names>
</name>
<name>
<surname>Aleshkin</surname>
<given-names>Andrey V.</given-names>
</name>
<name>
<surname>Emelyanenko</surname>
<given-names>Kirill A.</given-names>
</name>
<name>
<surname>Zulkarneev</surname>
<given-names>Eldar R.</given-names>
</name>
<name>
<surname>Kiseleva</surname>
<given-names>Irina A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Effective antibacterial nanotextured surfaces based on extreme wettability and bacteriophage seeding</article-title>. <source>ACS Appl. Nano Mater.</source> <volume>1</volume> (<issue>3</issue>), <fpage>1348</fpage>&#x2013;<lpage>1359</lpage>. <pub-id pub-id-type="doi">10.1021/acsanm.8b00090</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brescia</surname>
<given-names>Fabrizio</given-names>
</name>
<name>
<surname>Pittiruti</surname>
<given-names>Mauro</given-names>
</name>
<name>
<surname>Scoppettuolo</surname>
<given-names>Giancarlo</given-names>
</name>
<name>
<surname>Zanier</surname>
<given-names>Chiara</given-names>
</name>
<name>
<surname>Nadalini</surname>
<given-names>Elisa</given-names>
</name>
<name>
<surname>Bottos</surname>
<given-names>Paola</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients [J]</article-title>. <source>J. Vasc. Access</source> <volume>00</volume> (<issue>0</issue>), <fpage>1</fpage>&#x2013;<lpage>5</lpage>.</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chauhan</surname>
<given-names>Ashwini</given-names>
</name>
<name>
<surname>Bernardin</surname>
<given-names>Aude</given-names>
</name>
<name>
<surname>Mussard</surname>
<given-names>Windy</given-names>
</name>
<name>
<surname>Kriegel</surname>
<given-names>Irene</given-names>
</name>
<name>
<surname>Esteve</surname>
<given-names>Marc</given-names>
</name>
<name>
<surname>Ghigo</surname>
<given-names>Jean-Marc</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Preventing biofilm formation and associated occlusion by biomimetic glycocalyxlike polymer in central venous catheters</article-title>. <source>J. Infect. Dis.</source> <volume>210</volume> (<issue>9</issue>), <fpage>1347</fpage>&#x2013;<lpage>1356</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiu249</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costello</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>T. J.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>Surface modification of poly(tetrafluoroethylene) with benzoin dianion</article-title>. <source>Macromolecules</source> <volume>17</volume> (<issue>12</issue>), <fpage>2940</fpage>&#x2013;<lpage>2942</lpage>. <pub-id pub-id-type="doi">10.1021/ma00142a094</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dan</surname>
<given-names>Yoav</given-names>
</name>
<name>
<surname>Buzhor</surname>
<given-names>Marina</given-names>
</name>
<name>
<surname>Raichman</surname>
<given-names>Daniel</given-names>
</name>
<name>
<surname>Menashe</surname>
<given-names>Eti</given-names>
</name>
<name>
<surname>Rachmani</surname>
<given-names>Oren</given-names>
</name>
<name>
<surname>Amir</surname>
<given-names>Elizabeth</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Covalent surface functionalization of nonwoven fabrics with controlled hydrophobicity, water absorption, and pH regulation properties</article-title>. <source>J. Appl. Polym. Sci.</source> <volume>138</volume> (<issue>6</issue>), <fpage>e49820</fpage>. <pub-id pub-id-type="doi">10.1002/app.49820</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erathodiyil</surname>
<given-names>Nandanan</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>Hsi-Min</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Hong</given-names>
</name>
<name>
<surname>JackieYing</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Zwitterionic polymers and hydrogels for antibiofouling applications in implantable devices</article-title>. <source>Mater. Today</source> <volume>38</volume>, <fpage>84</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.mattod.2020.03.024</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faustino</surname>
<given-names>Celia M. C.</given-names>
</name>
<name>
<surname>Lemos</surname>
<given-names>Sara M. C.</given-names>
</name>
<name>
<surname>Monge</surname>
<given-names>Nuno</given-names>
</name>
<name>
<surname>IsabelRibeiro</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A scope at antifouling strategies to prevent catheter-associated infections</article-title>. <source>Adv. Colloid Interface Sci.</source> <volume>284</volume>, <fpage>102230</fpage>. <pub-id pub-id-type="doi">10.1016/j.cis.2020.102230</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>Janita</given-names>
</name>
<name>
<surname>Camargos Moreira</surname>
<given-names>Paulo Augusto</given-names>
</name>
<name>
<surname>Rosado</surname>
<given-names>Viviane</given-names>
</name>
<name>
<surname>HenriqueMourao</surname>
<given-names>PauloOrlandi</given-names>
</name>
<name>
<surname>Maia de Castro Romanelli</surname>
<given-names>Roberta</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Risk factors for central venous catheter-related bloodstream infection in neonates</article-title>. <source>Am. J. Infect. Control</source> <volume>48</volume> (<issue>9</issue>), <fpage>1102</fpage>&#x2013;<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajic.2019.12.004</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>Ruth</given-names>
</name>
<name>
<surname>Harron</surname>
<given-names>Katie</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>Quen</given-names>
</name>
<name>
<surname>Gamble</surname>
<given-names>Carrol</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Impregnated central venous catheters should be readily used to reduce risk of bloodstream infection</article-title>. <source>Br. Med. J.</source> <volume>347</volume>, <fpage>f7169</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.f7169</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goncalves</surname>
<given-names>Idalina</given-names>
</name>
<name>
<surname>Matama</surname>
<given-names>Teresa</given-names>
</name>
<name>
<surname>Cavaco-Paulo</surname>
<given-names>Artur</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>Carla</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Laccase coating of catheters with poly(catechin) for biofilm reduction</article-title>. <source>Biocatal. Biotransformation</source> <volume>32</volume> (<issue>1</issue>), <fpage>2</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.3109/10242422.2013.828711</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gunaratnam</surname>
<given-names>Gubesh</given-names>
</name>
<name>
<surname>Spengler</surname>
<given-names>Christian</given-names>
</name>
<name>
<surname>Trautmann</surname>
<given-names>Simone</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>Philipp</given-names>
</name>
<name>
<surname>Mischo</surname>
<given-names>Johannes</given-names>
</name>
<name>
<surname>Wieland</surname>
<given-names>Ben</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Human blood plasma factors affect the adhesion kinetics of <italic>Staphylococcus aureus</italic> to central venous catheters</article-title>. <source>Sci. Rep.</source> <volume>10</volume> (<issue>1</issue>), <fpage>20992</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-77168-x</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hitz</surname>
<given-names>Felicitas</given-names>
</name>
<name>
<surname>Klingbiel</surname>
<given-names>Dirk</given-names>
</name>
<name>
<surname>Omlin</surname>
<given-names>Aurelius</given-names>
</name>
<name>
<surname>Riniker</surname>
<given-names>Salome</given-names>
</name>
<name>
<surname>Zerz</surname>
<given-names>Andreas</given-names>
</name>
<name>
<surname>Cerny</surname>
<given-names>Thomas</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Athrombogenic coating of long-term venous catheter for cancer patients: A prospective, randomised, double-blind trial</article-title>. <source>Ann. Hematol.</source> <volume>91</volume> (<issue>4</issue>), <fpage>613</fpage>&#x2013;<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1007/s00277-011-1343-8</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Xu</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Deren</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Leyong</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Juanjuan</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Yiqing</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Preparation of a novel antibacterial coating precursor and its antibacterial mechanism</article-title>. <source>Appl. Surf. Sci.</source> <volume>465</volume>, <fpage>478</fpage>&#x2013;<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsusc.2018.09.160</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jana</surname>
<given-names>Basas</given-names>
</name>
<name>
<surname>Palau</surname>
<given-names>Marta</given-names>
</name>
<name>
<surname>Ratia</surname>
<given-names>Carlos</given-names>
</name>
<name>
<surname>Josedel Pozo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martin-Gomez</surname>
<given-names>Maria Teresa</given-names>
</name>
<name>
<surname>Gomis</surname>
<given-names>Xavier</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>High-dose daptomycin is effective as an antibiotic lock therapy in a rabbit model of staphylococcus epidermidis catheter-related infection [J]</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>62</volume> (<issue>2</issue>), <fpage>017777</fpage>. <pub-id pub-id-type="doi">10.1128/AAC.01777-17</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Linhua</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Li</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Yanbiao</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Hongchi</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Zhen</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Bo</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Superhydrophilic versus normal polydopamine coating: A superior and robust platform for synergistic antibacterial and antithrombotic properties</article-title>. <source>Chem. Eng. J.</source> <volume>402</volume>, <fpage>126196</fpage>. <pub-id pub-id-type="doi">10.1016/j.cej.2020.126196</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Mingyu</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Kunpeng</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Wenqi</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Nuoya</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Yanan</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Fanjun</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>A universal anti-thrombotic and antibacterial coating: A chemical approach directed by fenton reaction and silane coupling</article-title>. <source>Appl. Surf. Sci.</source> <volume>600</volume>, <fpage>154143</fpage>. <pub-id pub-id-type="doi">10.1016/j.apsusc.2022.154143</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Qiaohong</given-names>
</name>
<name>
<surname>Singha</surname>
<given-names>Priyadarshini</given-names>
</name>
<name>
<surname>Handa</surname>
<given-names>Hitesh</given-names>
</name>
<name>
<surname>Locklin</surname>
<given-names>Jason</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Covalent grafting of antifouling phosphorylcholine-based copolymers with antimicrobial nitric oxide releasing polymers to enhance infection-resistant properties of medical device coatings</article-title>. <source>Langmuir</source> <volume>33</volume> (<issue>45</issue>), <fpage>13105</fpage>&#x2013;<lpage>13113</lpage>. <pub-id pub-id-type="doi">10.1021/acs.langmuir.7b02970</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>Xiangtao</given-names>
</name>
<name>
<surname>York</surname>
<given-names>Emily A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Shu</given-names>
</name>
<name>
<surname>KevinEdgar</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Hydroboration&#x2013;oxidation: A chemoselective route to cellulose &#x3c9;-hydroxyalkanoate esters</article-title>. <source>Carbohydr. Polym.</source> <volume>133</volume>, <fpage>262</fpage>&#x2013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2015.06.080</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monzillo</surname>
<given-names>Vincenzina</given-names>
</name>
<name>
<surname>Corona</surname>
<given-names>Silvia</given-names>
</name>
<name>
<surname>Lanzarini</surname>
<given-names>Paolo</given-names>
</name>
<name>
<surname>Dalla Valle</surname>
<given-names>Claudia</given-names>
</name>
<name>
<surname>Marone</surname>
<given-names>Piero</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Chlorhexidine-silver sulfadiazine-impregnated central venous catheters: <italic>In vitro</italic> antibacterial activity and impact on bacterial adhesion</article-title>. <source>New Microbiol.</source> <volume>35</volume> (<issue>2</issue>), <fpage>175</fpage>&#x2013;<lpage>182</lpage>.</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozkan</surname>
<given-names>Ekrem</given-names>
</name>
<name>
<surname>Mondal</surname>
<given-names>Arnab</given-names>
</name>
<name>
<surname>Douglass</surname>
<given-names>Megan</given-names>
</name>
<name>
<surname>Hopkins</surname>
<given-names>Sean P.</given-names>
</name>
<name>
<surname>Garren</surname>
<given-names>Mark</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>Devine</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Bioinspired ultra-low fouling coatings on medical devices to prevent device-associated infections and thrombosis</article-title>. <source>J. Colloid Interface Sci.</source> <volume>608</volume>, <fpage>1015</fpage>&#x2013;<lpage>1024</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcis.2021.09.183</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pant</surname>
<given-names>Bishnu D.</given-names>
</name>
<name>
<surname>Benin</surname>
<given-names>Bogdan M.</given-names>
</name>
<name>
<surname>Abeydeera</surname>
<given-names>Nalin</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Min-Ho</given-names>
</name>
<name>
<surname>SongpingHuang</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Bi<sub>2</sub>O<sub>3</sub> nanoparticles exhibit potent broad-spectrum antimicrobial activity and the ability to overcome Ag-ciprofloxacin- and meropenem-resistance in <italic>P. aeruginosa</italic>: The next silver bullet of metal antimicrobials? [J]</article-title>. <source>Biomaterials Sci.</source> <volume>10</volume> (<issue>6</issue>), <fpage>1523</fpage>&#x2013;<lpage>1531</lpage>. <pub-id pub-id-type="doi">10.1039/d1bm01844b</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radu Mihu</surname>
<given-names>Mircea</given-names>
</name>
<name>
<surname>Cabral</surname>
<given-names>Vitor</given-names>
</name>
<name>
<surname>Pattabhi</surname>
<given-names>Rodney</given-names>
</name>
<name>
<surname>Tar</surname>
<given-names>Moses T.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>Kelvin P.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>Adam J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Sustained nitric oxide-releasing nanoparticles interfere with methicillin-resistant <italic>Staphylococcus aureus</italic> adhesion and biofilm formation in a rat central venous catheter model</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>61</volume> (<issue>1</issue>), <fpage>020200</fpage>. <pub-id pub-id-type="doi">10.1128/AAC.02020-16</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schalk</surname>
<given-names>Enrico</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>Timo</given-names>
</name>
<name>
<surname>Panse</surname>
<given-names>Jens</given-names>
</name>
<name>
<surname>Fiegle</surname>
<given-names>Eva</given-names>
</name>
<name>
<surname>Naendrup</surname>
<given-names>Jan-Hendrik</given-names>
</name>
<name>
<surname>Schmidt-Hieber</surname>
<given-names>Martin</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Central venous catheter-related bloodstream infections in patients with haematological malignancies during the SARS-CoV-2 pandemic</article-title>. <source>Br. J. Haematol.</source> <volume>199</volume> (<issue>4</issue>), <fpage>e16</fpage>&#x2013;<lpage>e20</lpage>. <pub-id pub-id-type="doi">10.1111/bjh.18442</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schindler</surname>
<given-names>Ralf</given-names>
</name>
<name>
<surname>Heemann</surname>
<given-names>Uwe</given-names>
</name>
<name>
<surname>Haug</surname>
<given-names>Ulrike</given-names>
</name>
<name>
<surname>Stoelck</surname>
<given-names>Benjamin</given-names>
</name>
<name>
<surname>Karatas</surname>
<given-names>Aysun</given-names>
</name>
<name>
<surname>Pohle</surname>
<given-names>Cosima</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization: A randomized controlled trial</article-title>. <source>Nephrol. Dial. Transplant.</source> <volume>25</volume> (<issue>8</issue>), <fpage>2651</fpage>&#x2013;<lpage>2656</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/gfq052</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimizu</surname>
<given-names>Yoshiyuki</given-names>
</name>
<name>
<surname>Hatachi</surname>
<given-names>Takeshi</given-names>
</name>
<name>
<surname>Takeshita</surname>
<given-names>Jun</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Inata</given-names>
</name>
<name>
<surname>Kyogoku</surname>
<given-names>Miyako</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>Yoshihiro</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Occurrence and risk factors for unplanned catheter removal in a PICU: Central venous catheters versus peripherally inserted central venous catheters</article-title>. <source>Pediatr. Crit. Care Med.</source> <volume>21</volume> (<issue>9</issue>), <fpage>E635</fpage>&#x2013;<lpage>E642</lpage>. <pub-id pub-id-type="doi">10.1097/pcc.0000000000002426</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>Kai</given-names>
</name>
<name>
<surname>Amal</surname>
<given-names>Alzahrani</given-names>
</name>
<name>
<surname>Khoddami</surname>
<given-names>Sara</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>Demian</given-names>
</name>
<name>
<surname>Kymora Scotland Cheng Yazdani</surname>
<given-names>B. John T. J. Hossein</given-names>
</name>
<name>
<surname>Ahmadabadi</surname>
<given-names>Yan</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Self-limiting mussel inspired thin antifouling coating with broad-spectrum resistance to biofilm formation to prevent catheter-associated infection in mouse and porcine models</article-title>. <source>Adv. Healthc. Mater.</source> <volume>10</volume> (<issue>6</issue>), <fpage>2001573</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.202001573</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>Kai</given-names>
</name>
<name>
<surname>JoeyLo</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Mei</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Xiaoqiang</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>Donald E.</given-names>
</name>
<name>
<surname>Hancock</surname>
<given-names>Robert E. W.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Anti-adhesive antimicrobial peptide coating prevents catheter associated infection in a mouse urinary infection model</article-title>. <source>Biomaterials</source> <volume>116</volume>, <fpage>69</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.11.047</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname>
<given-names>Yanlong</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Sirong</given-names>
</name>
<name>
<surname>Amirfazli</surname>
<given-names>Alidad</given-names>
</name>
<name>
<surname>Siddiqui</surname>
<given-names>Abdul Rahim</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Li</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Recent advances in antibacterial superhydrophobic coatings</article-title>. <source>Adv. Eng. Mater.</source> <volume>24</volume> (<issue>4</issue>), <fpage>2101053</fpage>. <pub-id pub-id-type="doi">10.1002/adem.202101053</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Shuai</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Liyun</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Xinjin</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>Vorstius</given-names>
</name>
<name>
<surname>Keatch</surname>
<given-names>Robert</given-names>
</name>
<name>
<surname>George</surname>
<given-names>Corner</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Enhanced antibacterial and antiadhesive activities of silver-PTFE nanocomposite coating for urinary catheters</article-title>. <source>ACS Biomaterials Sci. Eng.</source> <volume>5</volume> (<issue>6</issue>), <fpage>2804</fpage>&#x2013;<lpage>2814</lpage>. <pub-id pub-id-type="doi">10.1021/acsbiomaterials.9b00071</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Chao</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Yang</given-names>
</name>
<name>
<surname>Venkata Thappeta</surname>
<given-names>Kishore Reddy</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>JoThy Lachumy</given-names>
</name>
<name>
<surname>Pranantyo</surname>
<given-names>Dicky</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>En-Tang</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>
<italic>In vivo</italic> anti-biofilm and anti-bacterial non-leachable coating thermally polymerized on cylindrical catheter</article-title>. <source>ACS Appl. Mater. Interfaces</source> <volume>9</volume> (<issue>41</issue>), <fpage>36269</fpage>&#x2013;<lpage>36280</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.7b07053</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Tonghe</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Hongbing</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Hongmei</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Hongsheng</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Huitang</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>Xiumei</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Covalent grafting of PEG and heparin improves biological performance of electrospun vascular grafts for carotid artery replacement</article-title>. <source>Acta Biomater.</source> <volume>119</volume>, <fpage>211</fpage>&#x2013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2020.11.013</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>